

It's baaaaack...Canada's vitamin-banning Bill C-51 has been reworked as Bill C-6.
Stop Bill C-51 -- CODEX ALIMENTARIUS -- Call to Action from Anonymai on Vimeo.




Drinking copious cups of coffee isn’t just bad for your health, it’s also more likely to drive you crazy, or at least crazy enough to hear voices. According to a study published in the academic journal “Personal and Individual Differences,” people who consumed the equivalent of more than seven cups of coffee per day (330 mg) were more likely to have hallucinations than those who consumed less than one cup (10 mg).
'The majority of scientists and psychiatrists subscribe to the dopamine excess theory of schizophrenia--that too much dopamine is largely responsible for the symptoms of psychosis. However, since 1952, Dr. Abram Hoffer, the founding father of orthomolecular medicine, has researched, published, and expanded upon the adrenochrome theory of schizophrenia. (1,2) He and his colleagues, Drs. Osmond and Smythies, came to this theory by studying and researching the effects of substances such as mescaline, lysergic acid diethylamide (LSD), and amphetamines--all of which can cause a clinical syndrome in normal individuals that would be clinically indistinguishable from schizophrenia.
Hoffer noticed that mescaline had a similar chemical structure to that of adrenaline, and since both can be converted to indoles in the body, the potential schizophrenic toxin might be an indole derivative of adrenaline with similar neurochemical properties to that of mescaline or LSD. He eventually deduced that the schizophrenic toxin was an oxidized derivative of adrenaline known as adrenochrome. Since the early 1950s, Hoffer's adrenochrome theory has been validated due to the following findings:
* that adrenochrome and its close relatives--dopaminochrome (from dopamine) and noradrenochrome (from noradrenaline)--are present in the human brain, (3-5)
* that these compounds probably induce a combination of neurotoxic and mind-mood-altering effect, and (3-5)
* that reducing adrenochrome and its close relatives is therapeutic for the treatment of schizophrenia. (6)
The majority of schizophrenic patients (about 90%) who receive mainstream treatments remain unwell and nonfunctional for the rest of their lives despite receiving the most advanced drugs and social services currently available. (7) Estimates of first episode schizophrenics are a little more optimistic, reporting that of five recently diagnosed patients, one will recover sufficiently to live an almost normal life without medication or with very low doses of medication. (8) The economic costs of schizophrenia to society are enormous, amounting to approximately two million dollars for each schizophrenic patient over a 40-year course of the illness. (9)
In a recent publication examining the economic burden of schizophrenia in Canada, the direct and non-direct heath care costs associated with this disease were estimated to be 2.02 billion Canadian dollars in 2004. (10) In addition, when these figures were added to the high unemployment rate with additional productivity, morbidity, and mortality losses, the estimate reached 4.83 billion Canadian dollars, for a total cost estimate of 6.85 billion Canadian dollars in 2004. The authors of this report arrived at the following conclusion: "Despite significant improvements in the past decade in pharmacotherapy, programs, and services available for patients with schizophrenia, the economic burden of schizophrenia in Canada remains high."
The purpose of the report is to highlight the problems with the standard medical treatment of schizophrenia and to demonstrate that the addition of orthomolecular medicine provides patients with the best opportunity of living a reasonable quality of life. Common orthomolecular treatments are reviewed, including summaries of relevant clinical studies and prescribing information. Four patient cases are described to show the reader the potential benefits of this approach, as well as the difficulties with this approach when certain essential treatment components are lacking.'
Source
Drugs designed to target one aspect of aging also seem to help repair DNA damage and regulate gene activity, preventing them from going haywire with the stresses of time.
"In principle, we now could have a way of reversing the effects of aging," said David Sinclair, a Harvard University gerontologist and co-founder of Sirtris Pharmaceuticals, a company best-known for its development of an experimental drug called resveratrol.
Resveratrol and similar compounds activate an enzyme called SIRT1. The enzyme rejuvenates mitochondria, the machines that power our cells. Mitochondrial breakdown has been associated with many age-related diseases, including heart disease, diabetes and dementia. Several labs in addition to Sirtris are researching compounds that target mitochondria.
The new findings suggest that SIRT1 fixes DNA in addition to mitochondria.
Sinclair's team found that unless SIRT1 enzymes gathered at sites where DNA had started to unravel, other DNA repair proteins failed to arrive. This allowed damage to progress, eventually causing dormant genes to come alive, a process called deregulation.
Some researchers think gene deregulation is a cause of aging: As cells get older, they produce less SIRT1, ostensibly becoming less able to repair faulty DNA and suppress the dormant genes.
But in mice either given resveratrol or genetically engineered to produce extra SIRT1 on their own, repairs went smoothly and quickly.
"One idea of why we age is that DNA becomes damaged or mutated," said Sinclair, lead author of the research published Wednesday in Cell. "But perhaps the main culprit is the effect of genes switching on and off, and that should be reversible."

Feeding Minds, Feeding BodiesLink
Written by Rosalie Moscoe
Monday, 29 December 2008
Orthomolecular Nutrition to the Rescue!
My husband and I waved goodbye as we watched our son John (not his real name) board the plane, happily joking with his buddies. The year was 1989. John was 19, and headed for what we expected to be a wonderful youth tour overseas; indeed, for the first few weeks he called home to say what a good time he was having. But after the fourth week, we received a shocking phone call. The trip organizers were sending him home. John had become paranoid and delusional; he had been taken to a hospital after fainting at the top of a mountain.
We left on the next plane and returned with a young man who not only looked physically ill and emaciated but also was totally psychotic. We were devastated.
John was hospitalized for a short time and was released with antipsychotic medication. The doctor told us it was “psychosis”. His personality changed. Our outgoing, friendly, affectionate boy and talented musician now spent hours in his room, asleep. Awake, he suffered Parkinson-like tremors and tardive dyskinesia, a side effect of his medication.
His progress was negligible and within a year, he was hospitalized with symptoms of schizophrenia. Upon his release, John was marginally better. Schizophrenia prognosis was dim. What was to become of him?
Frantically I searched for answers. Traditional texts left me feeling hopeless. By sheer luck, I came across a book by psychiatrist, Dr. Abram Hoffer, M.D. PhD., psychiatrist, and a scholar of bio-chemistry. The book (now renamed Healing Schizophrenia) discussed diets with healthy nutrients, free of allergens that could help his condition. (Hoffer is the author of 31 books and 500 research papers.)
Also emphasized were nutrition health benefits of nutrients in supplement form such as Vitamin B3 (niacin) and Vitamin C – both natural and essential to the human body for restoring health along with other nutrients.
Orthomolecular medicine is the practice of optimizing health and treating disease by providing correct amounts of vitamins, minerals, amino acids, enzymes, essential fatty acids and other substances which are natural to the body’s environment. In other words, find out what’s missing in the body and brain and give it what it needs and wants. Orthomolecular treatments are also safe to use along with medication.